Extracellular RNA drives TNF-α/TNF-receptor-1 mediated cardiac ischemia/reperfusion injury: Mechanistic insights and therapeutic potential of RNase1
Pharmacological Research · 2025-11 · 221 · 107944
DOI: 10.1016/j.phrs.2025.107944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacological Research, 2025-11. Verfasst von Hector A Cabrera-Fuentes und 21 weiteren Autor:innen. Beteiligte Einrichtung: División de Estudios de Posgrado e Investigación, Tecnológico Nacional de México / Instituto Tecnológico de Tijuana, Tijuana, BC 22414, Mexico; R&D g…. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Myocardial Reperfusion Injury, Receptors, Tumor Necrosis Factor, Type I, RNA. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Von-Behring-Röntgen-Stiftung, Ministry of Education and Research, Romania, National Research Foundation.
Abstract (Originalsprache)
Myocardial ischemia/reperfusion (I/R) injury causes cardiomyocyte death and exacerbates inflammation. Emerging evidence implicates extracellular RNA (eRNA) and tumor necrosis factor-α (TNF-α) as key mediators. We hypothesize that eRNA released from ischemic cardiomyocytes amplifies I/R injury via TNF-α/TNF-receptor-1 (TNF-R1) signaling, and that hydrolysis of eRNA by RNase1 can attenuate I/R injury by disrupting this pathway. Here, we investigated the mechanistic role of eRNA and its interplay with TNF-α signaling in cardiac I/R injury, and evaluated the therapeutic potential of RNase1 and cyclosporine-A (CsA). In ST-segment elevation myocardial infarction patients, plasma eRNA levels were significantly elevated 2 h post-percutaneous coronary intervention (PCI), correlating positively with Creatine Kinase (CK). In murine I/R and hypoxia/reoxygenation models, eRNA released from stressed cardiomyocytes acted as a damage-associated molecular pattern, triggering TNF-α shedding via TACE/ADAM17 and activating TNF-R1-mediated inflammation, mPTP opening, and cell death. Genetic deletion of TNF-α or TNF-R1 abrogated eRNA-induced cytotoxicity, while TNF-receptor- 2 (TNF-R2) deficiency exacerbated injury. Pharmacological inhibition of TACE with TAPI suppressed TNF-α release and preserved cell viability. RNase1 effectively degraded eRNA, blocking upstream pro-inflammatory signaling, whereas CsA preserved mitochondrial integrity by preventing mPTP opening. Notably, RNase1 and CsA showed synergistic protection in vivo when administered at reperfusion, significantly reducing myocardial infarct size. These findings identify eRNA as both a biomarker and pathogenic mediator of myocardial I/R injury, and support a dual-targeted strategy using RNase1 and CsA to interrupt the TNF-α/TNF-R1-driven inflammatory and mitochondrial death pathways. Targeting both upstream inflammatory and downstream mitochondrial mechanisms represents a promising cardioprotective intervention for acute myocardial infarction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- División de Estudios de Posgrado e Investigación, Tecnológico Nacional de México / Instituto Tecnológico de Tijuana, Tijuana, BC 22414, Mexico; R&D group, Vice Presidency Scientific Research & Innovation, Imam Abdulrahm…
- Cardiovascular Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Campus Vall d'Hebron Hospital, Barcelona & Centro de Investigacion Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid,…
- Université de Lorraine, CNRS, Laboratoire IMoPA, UMR 7365, Nancy F-54000, France.
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; HeartDrug Research LLC, West Friendship, MD 21294, USA.
- Parasitology Laboratory, Department of Microbiology and Parasitology, Faculty of Medicine, Universidad Nacional Autónoma de Mexico (UNAM), Mexico City, Mexico.
- UNAM-UABJO Research Centre, Faculty of Medicine and Surgery, Universidad Autónoma Benito Juárez de Oaxaca (UABJO), Oaxaca 68120, Mexico; División de Estudios de Posgrado e Investigación, Tecnológico Nacional de México /…
Förderung
- Von-Behring-Röntgen-Stiftung
- Ministry of Education and Research, Romania
- National Research Foundation
- European Regional Development Fund
- Ministerio de Sanidad, Consumo y Bienestar Social
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
- European Commission
- Ministry of Health -Singapore
Zitieren
APA
Cabrera-Fuentes, H. A., Ruiz-Meana, M., Barreto, G., Serebruany, V. L., Sánchez-Vega, J. T., Pérez-Campos, E., Kostin, S., Böning, A., Jarquín González, E. E., Al-Suhaimi, E. A., Rodriguez-Montesinos, J., Inserte, J., Pedretti, S., Yap, J., Irei, J., Sedding, D. G., Lecour, S., Liehn, E. A., Garcia-Dorado, D., …, & Preissner, K. T. (2025). Extracellular RNA drives TNF-α/TNF-receptor-1 mediated cardiac ischemia/reperfusion injury: Mechanistic insights and therapeutic potential of RNase1. Pharmacological Research, 221, 107944. https://doi.org/10.1016/j.phrs.2025.107944
Vancouver
Cabrera-Fuentes HA, Ruiz-Meana M, Barreto G, Serebruany VL, Sánchez-Vega JT, Pérez-Campos E, et al. Extracellular RNA drives TNF-α/TNF-receptor-1 mediated cardiac ischemia/reperfusion injury: Mechanistic insights and therapeutic potential of RNase1. Pharmacological Research. 2025;221:107944. doi:10.1016/j.phrs.2025.107944
BibTeX
@article{CabreraFuentes2025,
author = {Cabrera-Fuentes, Hector A and Ruiz-Meana, Marisol and Barreto, Guillermo and Serebruany, Victor L and Sánchez-Vega, Jose T and Pérez-Campos, Eduardo and Kostin, Sawa and Böning, Andreas and Jarquín González, Efrén Emmanuel and Al-Suhaimi, Ebtesam A and Rodriguez-Montesinos, Julian and Inserte, Javier and Pedretti, Sarah and Yap, Jonathan and Irei, Jason and Sedding, Daniel G and Lecour, Sandrine and Liehn, Elisa A and Garcia-Dorado, David and Hausenloy, Derek J and Boisvert, William A and Preissner, Klaus T},
title = {Extracellular RNA drives TNF-α/TNF-receptor-1 mediated cardiac ischemia/reperfusion injury: Mechanistic insights and therapeutic potential of RNase1},
journal = {Pharmacological Research},
year = {2025},
volume = {221},
pages = {107944},
doi = {10.1016/j.phrs.2025.107944}
}
EUVIMED